Pharmacogenomic Factors Such as the Expression of Imatinib Transporters (OCT-1, ABCB-1 and ABCG-2) at Diagnosis, OCT-1 SNPs, and Steady-State Imatinib and Desmethyl-Imatinib Trough Plasma Levels in De Novo Chronic Phase Chronic Myelogenous Leukemia, May Influence Disease Response to ImatinibHélène Labussière, Franck E. Nicolini, Sandrine Hayette et al.|Blood|2008Cited by 11
Performances of Targeted RNA Sequencing for the Analysis of Fusion Transcripts, Gene Mutation, and Expression in Hematological MalignanciesSandrine Hayette, Pierre Sujobert, Marie Balsat et al.|HemaSphere|2021Cited by 10
Performances of targeted RNA-sequencing for the analysis of fusion transcripts, gene mutation and expression in haematological malignanciesSandrine Hayette, Pierre Sujobert, Béatrice Grange et al.|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 0
A baseline transcriptomic signature predictive of clinical response to menin inhibitors in AML : The PRE-men retrosprospective StudyVincent Alcazer, Maël Heiblig, Sandrine Hayette et al.|Blood|2025Cited by 0